Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes
2019-08
发表期刊NATURE CELL BIOLOGY (IF:17.3[JCR-2023],24.2[5-Year])
ISSN1465-7392
卷号21期号:8页码:1015-+
发表状态已发表
DOI10.1038/s41556-019-0359-5
摘要Human liver cancers, including hepatocellular carcinomas and intra-hepatic cholangiocarcinomas, are often diagnosed late with poor prognosis. A better understanding of cancer initiation could provide potential preventive therapies and increase survival. Models for studying human liver cancer initiation are largely missing. Here, using directly reprogrammed human hepatocytes (hiHeps) and inactivation of p53 and RB, we established organoids possessing liver architecture and function. HiHep organoids were genetically engineered to model the initial alterations in human liver cancers. Bona fide hepatocellular carcinomas were developed by overexpressing c-Myc. Excessive mitochondrion-endoplasmic reticulum coupling induced by c-Myc facilitated hepatocellular carcinoma initiation and seemed to be a target of preventive treatment. Furthermore, through the analysis of human intra-hepatic cholangiocarcinoma-enriched mutations, we demonstrate that the RAS-induced lineage conversion from hepatocytes to intra-hepatic cholangiocarcinoma cells can be prevented by the combined inhibition of Notch and JAK-STAT. Together, hiHep organoids represent a system that can be genetically manipulated to model cancer initiation and identify potential preventive therapies.
收录类别SCI ; SCIE
语种英语
资助项目National Science and Technology Major Project[2018ZX09711002-009]
WOS研究方向Cell Biology
WOS类目Cell Biology
WOS记录号WOS:000478029000013
出版者NATURE PUBLISHING GROUP
WOS关键词INTRAHEPATIC CHOLANGIOCARCINOMA ; HEPATOCELLULAR-CARCINOMA ; COLORECTAL-CANCER ; GENE-EXPRESSION ; ADULT LIVER ; CELL ; MITOCHONDRIA ; REVEALS ; MYC ; ENRICHMENT
原始文献类型Article
引用统计
正在获取...
文献类型期刊论文
条目标识符https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/61130
专题生命科学与技术学院_特聘教授组_惠利健组
通讯作者Zheng, Yun-Wen; Zheng, Shan; Hui, Lijian
作者单位
1.Univ Chinese Acad Sci, Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,State Key Lab C, Shanghai, Peoples R China
2.Fudan Univ, Dept Pediat Surg, Childrens Hosp, Shanghai, Peoples R China
3.Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Shanghai Inst Biol Sci, Key Lab Computat Biol, Shanghai, Peoples R China
4.Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Shanghai, Peoples R China
5.Chinese Acad Sci, Ctr Drug Safety Evaluat & Res, Shanghai Inst Mat Med, Shanghai, Peoples R China
6.Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai, Peoples R China
7.Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 5, Shanghai, Peoples R China
8.Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
9.Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan
10.Yokohama City Univ, Sch Med, Yokohama, Kanagawa, Japan
11.Jiangsu Univ, Inst Regenerat Med, Zhenjiang, Jiangsu, Peoples R China
12.Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
13.Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China
14.Chinese Acad Sci, Biores Innovat Ctr, Shanghai Inst Biochem & Cell Biol, Suzhou, Peoples R China
通讯作者单位生命科学与技术学院
推荐引用方式
GB/T 7714
Sun, Lulu,Wang, Yuqing,Cen, Jin,et al. Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes[J]. NATURE CELL BIOLOGY,2019,21(8):1015-+.
APA Sun, Lulu.,Wang, Yuqing.,Cen, Jin.,Ma, Xiaolong.,Cui, Lei.,...&Hui, Lijian.(2019).Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes.NATURE CELL BIOLOGY,21(8),1015-+.
MLA Sun, Lulu,et al."Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes".NATURE CELL BIOLOGY 21.8(2019):1015-+.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Sun, Lulu]的文章
[Wang, Yuqing]的文章
[Cen, Jin]的文章
百度学术
百度学术中相似的文章
[Sun, Lulu]的文章
[Wang, Yuqing]的文章
[Cen, Jin]的文章
必应学术
必应学术中相似的文章
[Sun, Lulu]的文章
[Wang, Yuqing]的文章
[Cen, Jin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。